Benzafibrate Dispersible Tablets
Belongs to Category:
The company has production licenses for tablets, capsules, granules, suppositories, powders, injections, oral solutions, dry suspensions, and eye drops.
Product Description
Approval Number:
H20070265
Indications:
For the treatment of: Hypertriglyceridemia, Hypercholesterolemia, Mixed hyperlipidemia.
Administration:
Dosage for Adults:
Standard regimen: 0.2-0.4g three times daily, to be taken after meals or with food. Maintenance dose (for optimal responders): 0.4g twice daily.
Renal Impairment Adjustment (by creatinine clearance rate):
40-60 mL/min: 0.4g twice daily
15-40 mL/min: 0.4g once daily or every other day
<15 mL/min: 0.4g every 3 days
Specifications:
10mg x 7 tablets, 10mg x 10 tabl
The company has production licenses for tablets, capsules, granules, suppositories, powders, injections, oral solutions, dry suspensions, and eye drops.
The main products cover cardiovascular diseases, diabetic complications, anti-tumor, calcium supplementation, digestive system, respiratory system, and orthopedics.
Related Products
Online Message
We will contact you within one business day. Please pay attention to your email.
Email: marcos.yuan@wangao.com.cn
Address: No. 688, Dinghai Road, Haimen City, Jiangsu Province
Mobile Version QR Code
WeChat Official Account
Copyright © 2025 Jiangsu Wangao Pharmaceutical Co., Ltd.